Skip to content

Comparison of Efficacy Between ILM Forceps

A Comparison of the Efficacy of 25g Grieshaber Sharkskin ILM Forceps With Reflex Handle vs Standard 25g Grieshaber ILM Forceps for Internal Limiting Membrane Peeling

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06536569
Enrollment
56
Registered
2024-08-05
Start date
2025-07-01
Completion date
2026-01-01
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane, Macular Holes

Brief summary

This study is a Single center, prospective, observational, multi surgeon randomized controlled trial. Subjects will be assessed pre-operatively, operatively and at 1 month postoperatively. Clinical evaluations will include measurement of visual acuity and optical coherence tomography (OCT).

Interventions

DEVICEInternal limiting membrane (ILM) Peeling with Sharkskin Forceps

25g Grieshaber Sharkskin ILM Forceps with Reflex Handle

DEVICEInternal limiting membrane (ILM) Peeling with Standard Forceps

25g Grieshaber Standard ILM Forceps

Sponsors

Sengi
CollaboratorINDUSTRY
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• 19y and older patients with symptomatic ERM (grade 2-3) or Macular hole (non flap-requiring) for elective ILM peeling surgery.

Exclusion criteria

* Co-morbid diabetic retinopathy of any grade. * Neovascular AMD. * Previous vitrectomy. * Previous retinal detachment treated with scleral buckle or pneumatic retinopexy. * Uncontrolled glaucoma or previous glaucoma surgery. * Combined phacovitrectomy. * Macula holes with severity requiring flap.

Design outcomes

Primary

MeasureTime frameDescription
Number of attempts to initiate peelingSurgery (Operative Visit)Evaluated by recorded video

Secondary

MeasureTime frameDescription
Number of handle-ReSite/widefield viewing system lens touchesSurgery (Operative Visit)Evaluated by recorded video
Duration of PeelSurgery (Operative Visit)Start to completion of peel
Number of deep retinal graspsSurgery (Operative Visit)Evaluated by recorded video

Other

MeasureTime frame
Corrected Distance Visual Acuity1 Month Postoperatively

Countries

Canada

Contacts

Primary ContactBryon McKay, MD, PhD
mckaybr.phd@gmail.com604 806 9090

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026